Cargando…
Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids
With its strong effect on vector-borne diseases, and insecticidal effect on mosquito vectors of malaria, inhibition of sporogonic and blood-stage development of Plasmodium falciparum, as well as in vitro and in vivo impairment of the P. berghei development inside hepatocytes, ivermectin (IVM) contin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755717/ https://www.ncbi.nlm.nih.gov/pubmed/35022455 http://dx.doi.org/10.1038/s41598-021-04532-w |
_version_ | 1784632428923453440 |
---|---|
author | Singh, Lovepreet Fontinha, Diana Francisco, Denise Prudêncio, Miguel Singh, Kamaljit |
author_facet | Singh, Lovepreet Fontinha, Diana Francisco, Denise Prudêncio, Miguel Singh, Kamaljit |
author_sort | Singh, Lovepreet |
collection | PubMed |
description | With its strong effect on vector-borne diseases, and insecticidal effect on mosquito vectors of malaria, inhibition of sporogonic and blood-stage development of Plasmodium falciparum, as well as in vitro and in vivo impairment of the P. berghei development inside hepatocytes, ivermectin (IVM) continues to represent an antimalarial therapeutic worthy of investigation. The in vitro activity of the first-generation IVM hybrids synthesized by appending the IVM macrolide with heterocyclic and organometallic antimalarial pharmacophores, against the blood-stage and liver-stage infections by Plasmodium parasites prompted us to design second-generation molecular hybrids of IVM. Here, a structural modification of IVM to produce novel molecular hybrids by using sub-structures of 4- and 8-aminoquinolines, the time-tested antiplasmodial agents used for treating the blood and hepatic stage of Plasmodium infections, respectively, is presented. Successful isolation of regioisomers and epimers has been demonstrated, and the evaluation of their in vitro antiplasmodial activity against both the blood stages of P. falciparum and the hepatic stages of P. berghei have been undertaken. These compounds displayed structure-dependent antiplasmodial activity, in the nM range, which was more potent than that of IVM, its aglycon or primaquine, highlighting the superiority of this hybridization strategy in designing new antiplasmodial agents. |
format | Online Article Text |
id | pubmed-8755717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-87557172022-01-13 Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids Singh, Lovepreet Fontinha, Diana Francisco, Denise Prudêncio, Miguel Singh, Kamaljit Sci Rep Article With its strong effect on vector-borne diseases, and insecticidal effect on mosquito vectors of malaria, inhibition of sporogonic and blood-stage development of Plasmodium falciparum, as well as in vitro and in vivo impairment of the P. berghei development inside hepatocytes, ivermectin (IVM) continues to represent an antimalarial therapeutic worthy of investigation. The in vitro activity of the first-generation IVM hybrids synthesized by appending the IVM macrolide with heterocyclic and organometallic antimalarial pharmacophores, against the blood-stage and liver-stage infections by Plasmodium parasites prompted us to design second-generation molecular hybrids of IVM. Here, a structural modification of IVM to produce novel molecular hybrids by using sub-structures of 4- and 8-aminoquinolines, the time-tested antiplasmodial agents used for treating the blood and hepatic stage of Plasmodium infections, respectively, is presented. Successful isolation of regioisomers and epimers has been demonstrated, and the evaluation of their in vitro antiplasmodial activity against both the blood stages of P. falciparum and the hepatic stages of P. berghei have been undertaken. These compounds displayed structure-dependent antiplasmodial activity, in the nM range, which was more potent than that of IVM, its aglycon or primaquine, highlighting the superiority of this hybridization strategy in designing new antiplasmodial agents. Nature Publishing Group UK 2022-01-12 /pmc/articles/PMC8755717/ /pubmed/35022455 http://dx.doi.org/10.1038/s41598-021-04532-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Singh, Lovepreet Fontinha, Diana Francisco, Denise Prudêncio, Miguel Singh, Kamaljit Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids |
title | Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids |
title_full | Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids |
title_fullStr | Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids |
title_full_unstemmed | Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids |
title_short | Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids |
title_sort | synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755717/ https://www.ncbi.nlm.nih.gov/pubmed/35022455 http://dx.doi.org/10.1038/s41598-021-04532-w |
work_keys_str_mv | AT singhlovepreet synthesisandantiplasmodialactivityofregioisomersandepimersofsecondgenerationdualactingivermectinhybrids AT fontinhadiana synthesisandantiplasmodialactivityofregioisomersandepimersofsecondgenerationdualactingivermectinhybrids AT franciscodenise synthesisandantiplasmodialactivityofregioisomersandepimersofsecondgenerationdualactingivermectinhybrids AT prudenciomiguel synthesisandantiplasmodialactivityofregioisomersandepimersofsecondgenerationdualactingivermectinhybrids AT singhkamaljit synthesisandantiplasmodialactivityofregioisomersandepimersofsecondgenerationdualactingivermectinhybrids |